Vincent Delwail

Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

Steven M. Horwitz, Owen A. O’Connor, Barbara Pro et al. · The Lancet · 2018 · 726 citations · Full text

Medicine, Hematology, Oncology +12

Primary intracerebral malignant lymphoma: report of 248 cases

B. Bataille, Vincent Delwail, Emmanuelle Menet et al. · Journal of neurosurgery · 2000 · 595 citations

Medicine, Oncology, Pathology +16

A uniform activated B-cell–like immunophenotype might explain the poor prognosis of primary central nervous system lymphomas: analysis of 83 cases

Sophie Camilleri‐Broët, Emmanuelle Crinière, Philippe Broët et al. · Blood · 2005 · 373 citations · Full text

Medicine, Oncology, Pathology +11

Obinutuzumab plus bendamustine versus bendamustine monotherapy in patients with rituximab-refractory indolent non-Hodgkin lymphoma (GADOLIN): a randomised, controlled, open-label, multicentre, phase 3 trial

Laurie H. Sehn, Neil Chua, Marek Trněný et al. · The Lancet Oncology · 2016 · 343 citations

Medicine, Oncology, Pharmacology +13

Initial Treatment of Aggressive Lymphoma with High-Dose Chemotherapy and Autologous Stem-Cell Support

Nöel Milpied, Éric Deconinck, Fanny Gaillard et al. · New England Journal of Medicine · 2004 · 341 citations · Full text

Medicine, Hematology, Oncology +13